发明名称 PIPERIDIN-2-ONE DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THESE COMPOUNDS AS THE ACTIVE INGREDIENT
摘要 A piperidin-2-one derivative compound represented by formula (I): <CHEM> wherein all symbols are described in the specification, or a non-toxic salt thereof. <??>The compound represented by formula (I) inhibits activation of p38MAP kinase, and is useful for prevention and/or treatment of various inflammatory diseases, rheumatoid arthritis, osteoarthritis, arthritis, osteoporosis, autoimmune diseases, infectious diseases, sepsis, cachexia, cerebral infarction, Alzheimer's disease, asthma, chronic pulmonary inflammatory diseases, reperfusion injury, thrombosis, glomerulonephritis, diabetes, graft versus host rejection, inflammatory bowel disease, Crohn's disease, ulcerative colitis, multiple sclerosis, tumor growth and metastasis, multiple myeloma, plasma cell leukemia, Castleman's disease, atrial myxoma, psoriasis, dermatitis, gout, adult respiratory distress syndrome (ARDS), arteriosclerosis, post-percutaneous transluminal coronary angioplasty (PTCA) restenosis or pancreatitis. <IMAGE>
申请公布号 EP1447401(A1) 申请公布日期 2004.08.18
申请号 EP20020783591 申请日期 2002.11.21
申请人 ONO PHARMACEUTICAL CO., LTD. 发明人 TAKAHASHI, K.;YAMAMOTO, S.;NAKA, M.
分类号 A61K31/4433;A61K31/451;A61K31/4535;A61K31/454;A61K31/4545;A61K31/495;A61K31/496;A61K31/513;A61K31/535;A61K31/5375;A61K31/5377;A61P1/04;A61P1/18;A61P3/10;A61P7/00;A61P7/02;A61P9/00;A61P9/10;A61P11/00;A61P11/06;A61P13/12;A61P17/00;A61P17/06;A61P19/00;A61P19/02;A61P19/06;A61P19/10;A61P25/00;A61P25/28;A61P29/00;A61P31/00;A61P31/04;A61P35/00;C07D211/76;C07D211/86;C07D211/96;C07D239/10;C07D241/08;C07D265/10;C07D265/32;C07D401/10;C07D401/12;C07D405/12;C07D409/06;C07D413/08;C07D417/04;(IPC1-7):C07D211/76;C07D211/88;C07D413/10;A61K31/537;A61K31/453;A61K31/443 主分类号 A61K31/4433
代理机构 代理人
主权项
地址